Figures & data
Table 1. Characteristics of the study population.
Table 2. Markers of clinical chemistry and hematology of the renal transplant recipients.
Table 3. Oxidative stress characteristics of the renal transplant recipients.
Figure 1. Modulation of selected biochemical and hematological parameters in patients, 1 year after KT. The data are expressed as median, the first quartile, and the third quartile of percentage of changes in parameters at day 360 and at day 0.
![Figure 1. Modulation of selected biochemical and hematological parameters in patients, 1 year after KT. The data are expressed as median, the first quartile, and the third quartile of percentage of changes in parameters at day 360 and at day 0.](/cms/asset/4790df78-176c-4e97-bc4d-5b3834384c4e/irnf_a_699874_f0001_b.gif)
Figure 2. Modulation of select parameters of antioxidant status and OS in patients 1 year after KT. The results are expressed as median, the first quartile, and the third quartile of percentage of changes in parameters at day 360 and at day 0.
![Figure 2. Modulation of select parameters of antioxidant status and OS in patients 1 year after KT. The results are expressed as median, the first quartile, and the third quartile of percentage of changes in parameters at day 360 and at day 0.](/cms/asset/5e510995-282d-4047-bf1e-7790ff9f77d9/irnf_a_699874_f0002_b.gif)
Table 4. Markers of clinical chemistry and hematology of the renal transplant recipients treated with CyA and Tac.
Table 5. OS characteristics of the renal transplant recipients treated with CyA and Tac.